The U.S. Food and Drug Administration (USFDA) issued an emergency use authorization (EUA) for a new monoclonal antibody for the treatment of COVID-19 that retains activity against the omicron variant. The EUA for Bebtelovimab is for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age and older we...

JAMA Network Anemia is the most widespread nutritional deficiency among pregnant females in the world. A total of 40.05% of pregnant females worldwide had anemia during pregnancy, with the highest prevalence (48.15%) in Southeast Asia. Because of the high prevalence of anemia, any adverse maternal and fetal outcomes associated with...

European Journal of Neurology: Neurological complications associated with acute coronavirus disease 2019 (COVID-19) are well described. Now, increasing evidence suggests that symptoms may persist even beyond 4–12 weeks after disease onset Frequent neurological, cognitive and neuropsychiatric long-term symptoms after COVID-19 include b...

Osteoporosis is a bone disorder that increases a person’s risk of fracture due to low bone mineral density (BMD), impaired bone microarchitecture/mineralization, and/or decreased bone strength. Osteoporotic fractures most commonly occur at the hip, spine and wrist. Fracture prevalence increases dramatically with age. The majority of pos...

Journal of the American College of Cardiology (JACC): Published on Feb 2021 Calcium and Vitamin D supplements are commonly used, often together, to optimize bone health. Multiple observational studies have linked low serum 25-hydroxyvitamin D concentrations with increased cardiovascular risk. Given their widespread availability, lo...

Calcium and vitamin D supplements needs for prevention of osteoporosis and osteoporotic fractures. There is evidence of significant benefit in people at risk of deficiency.For individuals who cannot get enough calcium through their diets, supplements may be beneficial. These should be limited to 500-600 mg per day and it is generally recommende...

An Endocrine Society Guideline UpdateWhat Is the Definition of Postmenopausal Osteoporosis?Osteoporosis is defined as “a [silent] skeletal disorder characterized by compromised bone strength predisposing to an increased risk of fracture. Bone strength reflects the integration of two main features: bone density and bone quality” RemoveAvailable...